The United States Pharmacopeia (USP), a nonprofit organization that sets quality standards for medicines, has issued a new report highlighting […]
This week, several important updates in the pharmaceutical industry could affect how medicines and vaccines are developed, distributed, and supplied
Oxford BioTherapeutics (OBT) has started a long-term partnership with Bristol Myers Squibb (BMS) to create and develop new cancer therapies
Artificial Intelligence (AI) is being talked about as the future of drug development, with promises of faster, smarter, and more
A recent study has found that combining an antidepressant with a small molecule drug called Caplyta (lumateperone) can significantly improve
BioNTech, the German biotech company known for its COVID-19 vaccine, has announced plans to close its Singapore manufacturing plant and
A second weight-loss pill, called Foundayo (orforglipron), has just been approved in the U.S. by the FDA. This new medication
A new medication called elegrobart, developed by Viridian Therapeutics, has shown encouraging results in a large clinical trial for people
Pharmaceutical companies now have more ways than ever to communicate with doctors and other healthcare providers (HCPs). These include traditional
Two large clinical trials, called OBERON and TITANIA, have shown that a new medication called tozorakimab significantly reduces the number